Technion – Israel Institute of Technology-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2024

  1. Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial

    Journal of Clinical Oncology

  2. Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial

    Annals of Oncology, Vol. 35, Núm. 11, pp. 981-992

2020

  1. Exploring the inner environment of protein hydrogels with fluorescence spectroscopy towards understanding their drug delivery capabilities

    Journal of Materials Chemistry B, Vol. 8, Núm. 31, pp. 6964-6974

  2. Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

    Obstetrical and Gynecological Survey

2019

  1. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 12, pp. 2427-2436

  2. Niraparib in patients with newly diagnosed advanced ovarian cancer

    New England Journal of Medicine, Vol. 381, Núm. 25, pp. 2391-2402

2018

  1. Elastic serum-albumin based hydrogels: Mechanism of formation and application in cardiac tissue engineering

    Journal of Materials Chemistry B, Vol. 6, Núm. 35, pp. 5604-5612